Home/Filings/4/0001209191-23-003988
4//SEC Filing

Levisetti Matteo 4

Accession 0001209191-23-003988

CIK 0001645460other

Filed

Jan 18, 7:00 PM ET

Accepted

Jan 19, 4:02 PM ET

Size

5.4 KB

Accession

0001209191-23-003988

Insider Transaction Report

Form 4
Period: 2023-01-17
Levisetti Matteo
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2023-01-17+110,000110,000 total
    Exercise: $3.36Exp: 2033-01-16Common Stock (110,000 underlying)
Footnotes (1)
  • [F1]This stock option grant becomes exercisable in eight equal semi-annual installments beginning on 7/17/2023

Issuer

Cue Biopharma, Inc.

CIK 0001645460

Entity typeother

Related Parties

1
  • filerCIK 0001962444

Filing Metadata

Form type
4
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 4:02 PM ET
Size
5.4 KB